Wave Life Sciences (WVE) Operating Expenses (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Operating Expenses data on file, last reported at $76.1 million in Q2 2026.

• Quarterly Operating Expenses rose 23.78% year-over-year to $76.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $283.3 million (up 19.3% YoY) and the FY2025 annual result came in at $258.1 million, up 18.02% from the prior year.
• Operating Expenses grew to $76.1 million in Q2 2026, from $69.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $76.1 million in Q2 2026 to a low of $39.2 million in Q3 2022.
• A 5-year average of $53.9 million and a median of $51.2 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses dropped 11.01% — and 2024, when it grew 27.32%.
• Tracing WVE's Operating Expenses over 5 years: stood at $44.8 million in 2022, then advanced by 6.55% to $47.7 million in 2023, then grew by 27.32% to $60.8 million in 2024, then gained by 21.27% to $73.7 million in 2025, then advanced by 3.2% to $76.1 million in 2026.
• The last three Operating Expenses figures came in at $76.1 million (Q2 2026), $69.5 million (Q1 2026), and $73.7 million (Q4 2025), per Business Quant data.